(PharmaNewsWire.Com, January 07, 2017 ) According to the report United States Psoriasis Drugs Market, published by Market Data Forecast, the market is projected to reach USD 4.4 billion with a CAGR of 6.91% from USD 7.6 billion in 2016.
Psoriasis is noncommunicable, inflammatory skin condition that alters the life cycle of skin cells by speeding up the cell building process on the surface of the skin. Quick advancement of cells provide thick, silver scales, and makes the skin red, dry, flaky, and itchy. The different types of psoriasis are vulgaris, guttate, inverse, pustular, palmoplantar, erythrodermic, nail, and scalp psoriasis. Currently, no permanent cure is accessible for the disease; however preventative measures can be acquired to slow down the growth of cells on the surface of the skin. These medications when regulated, either by applying on the skin, or consumed orally, or through injections, specifically block parts of immune system process by targeting Tumour Necrosis Factor, Phosphodiesterase Type 4, Interleukin, among others.
The expansion of Psoriasis Drugs market is chiefly driven by factors such as increasing healthcare expenditure, boost in psoriasis Research and Development investment, initiation of novel and more efficient drug, and inclining demand of psoriasis medicines in emerging economies. In addition to this, psoriasis requires long term treatment as it can reoccur after the first line treatment, thereby inclining sales revenue. People seeking treatment for Psoriasis are also showing interest in combination therapies. A combination therapy of Topical and Systemic (Alefacept, etanercept, and others taken with methotrexate) have shown better results in patient. Expected entry of late-stage pipeline products are expected to accelerate the development of the product.
Based on Drug Type Pharmaceuticals Biopharmaceuticals Based on Route of Administration Topical Systemic Oral Intravenous Others Based on Target Tumour Necrosis Factor (TNF) Phosphodiesterase Type 4 (PDE4) Interleukin Others
The major companies dominating the market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Pharmaceuticals Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: